SEC Form 4 · accession 0001179110-15-004218
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Marth
Officer — President and CEO · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | A | 58,651 | $17.05 | A | 393,907 | D | |
| Common Stock | Jan 22, 2015 | A | 940 | $13.84 | A | 394,847 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Albany Molecular Research, Inc. Second Amended 1998 Employee Stock Purchase Plan.